ELIXIRON
Elixiron Immunotherapeutics Inc..
Launch date
Employees
Market cap
-
Enterprise valuation
$55—83m (Dealroom.co estimates Mar 2024.)
台北市 Taiwan (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
* | $1.0m | Grant | |
$27.0m | Series A | ||
* | N/A | Grant | |
* | N/A | CNY100m | Series B |
Total Funding | $41.8m |
Recent News about ELIXIRON
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.